Profit before tax (PBT) stood at Rs 493.13 crore in Q1 FY26, up 12.78% year on year (YoY).

Total expenses increased 10.97% to Rs 1,318.06 crore in Q1 FY26 as against Rs 1,187.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 146.18 crore (down 0.06% YoY), employee benefit expense was at Rs 168.01 crore (up 4.31% YoY) and finance cost was at Rs 5.82 crore (up 111.63% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.